SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001640334-20-002056
Filing Date
2020-08-12
Accepted
2020-08-12 16:41:53
Documents
7
Period of Report
2020-08-07
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K embi_8k.htm 8-K 22248
2 SEPARATION AND RELEASE AGREEMENT embi_ex101.htm EX-10.1 32062
3 EMPLOYMENT AGREEMENT embi_ex102.htm EX-10.2 62066
4 EMPLOYMENT AGREEMENT embi_ex103.htm EX-10.3 5306
5 PRESS RELEASE embi_ex991.htm EX-99.1 10242
6 embi_ex991img6.jpg GRAPHIC 4363
7 embi_ex991img7.jpg GRAPHIC 4682
  Complete submission text file 0001640334-20-002056.txt   146207
Mailing Address 5910 PACIFIC CENTER BLVD, SUITE 320 SAN DIEGO CA 92121
Business Address 5910 PACIFIC CENTER BLVD, SUITE 320 SAN DIEGO CA 92121 (949) 480-9051
Emerald Bioscience, Inc. (Filer) CIK: 0001516551 (see all company filings)

IRS No.: 450692882 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-55136 | Film No.: 201095938
SIC: 2834 Pharmaceutical Preparations